Staphylococcus lugdunensis is a coagulase-negative staphylococci (CoNS), commonly found on human skin. While most CoNS bacteria are typically considered clinically harmless, recent studies have shown ...

Researchers show that pediatric Staphylococcus lugdunensis infections are a cause for concern and may be associated with ventriculoperitoneal shunts Their results confirm that flucloxacillin can be ...

Methicillin Resistant Staphylococcus aureus (MRSA) is the major cause for nosocomial infections (hospital acquired infections). Scientists from University of Tubingen, Germany have discovered a new ...

SAN DIEGO — Staphylococcus lugdunensis is underestimated as a cause of hospital-acquired osteoarticular infection, and should be treated aggressively, researchers reported here at the Interscience ...

A potential lifesaver lies unrecognized in the human body: Scientists have discovered that Staphylococcus lugdunensis which colonizes in the human nose produces a previously unknown antibiotic. As ...

Background. Staphylococcus lugdunensis is an emerging cause of endocarditis. To cause endovascular infections, S. lugdunensis requires mechanisms to overcome shear stress. We investigated whether ...

Discover how antibiotic resistant bacteria are challenged by new antibiotics like lugdunin from Staphylococcus lugdunensis in our noses. Antibiotic-resistant bacteria are rising and there are few new ...

Your mother told you early and often not to stick your finger up there. But scientists say they have reached into the human nose and picked out something really special — a potential new medicine to ...

TüBINGEN, Germany, July 27 (UPI) --Researchers in Germany found a previously unknown antibiotic in the last place anybody expected it to be: the human nose. The bacteria Staphylococcus lugdunensis, ...

With antibiotic-resistant super bugs on the rise, researchers are on an urgent hunt for other bacteria that might yield chemicals we can harness as powerful drugs. Scientists once found most of these ...

A new type of antibiotic that is capable of fighting off some superbugs has been discovered in the human nose. The new drug, named lugdunin, originates from bacteria present in human nostrils.